Skip to content

LOW DERMA™ Highlights:

  • 1st to obtain U.S. FDA 510(k) clearance for Low Dermatitis Potential Claim
  • 1st to obtain U.S. FDA 510 (k) clearance for Protection Against Fentanyl
  • 1st to obtain HALAL certification by JAKIM Malaysia
  • Tested up to 26 types of Chemicals Permeation (EN16523-1 & ASTM F739)
  • Tested up to 15 types of Chemotherapy Drugs (ASTM D6978)
  • Tested for Viral Penetration (ISO 16604:2014 & ASTM F1671)

Visit us at Booth #47 or visit www.lowderma.com to know more about LOW DERMA™ Technology.
For enquiry, email us at info@lowderma.com

 

×

Join us in Prague for

the 2nd edition of BOOST!

Secure your spot (limited seats available!)

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy — the shortage of medicine and medical devices.

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.